全文获取类型
收费全文 | 3478篇 |
免费 | 193篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 156篇 |
妇产科学 | 76篇 |
基础医学 | 425篇 |
口腔科学 | 121篇 |
临床医学 | 242篇 |
内科学 | 773篇 |
皮肤病学 | 87篇 |
神经病学 | 369篇 |
特种医学 | 144篇 |
外科学 | 467篇 |
综合类 | 17篇 |
预防医学 | 205篇 |
眼科学 | 85篇 |
药学 | 253篇 |
中国医学 | 6篇 |
肿瘤学 | 232篇 |
出版年
2023年 | 18篇 |
2022年 | 36篇 |
2021年 | 79篇 |
2020年 | 53篇 |
2019年 | 69篇 |
2018年 | 94篇 |
2017年 | 84篇 |
2016年 | 68篇 |
2015年 | 75篇 |
2014年 | 96篇 |
2013年 | 131篇 |
2012年 | 162篇 |
2011年 | 196篇 |
2010年 | 117篇 |
2009年 | 108篇 |
2008年 | 194篇 |
2007年 | 185篇 |
2006年 | 176篇 |
2005年 | 164篇 |
2004年 | 142篇 |
2003年 | 149篇 |
2002年 | 160篇 |
2001年 | 112篇 |
2000年 | 119篇 |
1999年 | 94篇 |
1998年 | 48篇 |
1997年 | 40篇 |
1996年 | 45篇 |
1995年 | 33篇 |
1994年 | 29篇 |
1993年 | 27篇 |
1992年 | 57篇 |
1991年 | 59篇 |
1990年 | 69篇 |
1989年 | 55篇 |
1988年 | 47篇 |
1987年 | 45篇 |
1986年 | 40篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 24篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 19篇 |
1976年 | 12篇 |
1975年 | 14篇 |
1970年 | 8篇 |
1969年 | 10篇 |
1966年 | 8篇 |
排序方式: 共有3701条查询结果,搜索用时 15 毫秒
991.
Amyotrophic lateral sclerosis: an epidemiological study in the Province of Messina, Italy, 1976-1985
P De Domenico C E Malara L Marabello R M Puglisi F Meneghini S Serra G Gallitto R Musolino 《Neuroepidemiology》1988,7(3):152-158
An epidemiological investigation of 41 subjects with amyotrophic lateral sclerosis observed in the Province of Messina during 1976-1985 was performed. The incidence was 0.61/100,000 and the prevalence 2.48/100,000 inhabitants. The illness was found to be prevalent in males. The atrophic type occurred in 17 subjects, the bulbar type in 23 cases and the pseudo-polyneuritic form in only one patient. The mean age on the onset was 57.29 +/- 10.55 years. The duration of the illness was significantly higher in patients with atrophic type (p less than 0.01). No significant difference between occupation and development of the disease was found. Among all patients 12.19% presented evidence of trauma, but traumatic events were equally present in a control group. 相似文献
992.
Mitochondria play a multidimensional role in the function and the vitality of the neurological system. From the generation of neural stem cells to the maintenance of neurons and their ultimate demise, mitochondria play a critical role in regulating our neural pathways’ homeostasis, a task that is critical to our cognitive health and neurological well-being. Mitochondria provide energy via oxidative phosphorylation for the neurotransmission and generation of an action potential along the neuron’s... 相似文献
993.
994.
Salvatore Brugaletta Josep Gomez-Lara Luis Ortega-Paz Victor Jimenez-Diaz Marcelo Jimenez Pilar Jiménez-Quevedo Roberto Diletti Vicente Mainar Gianluca Campo Antonio Silvestro Jaume Maristany Xacobe Flores Loreto Oyarzabal Antonio De Miguel-Castro Andrés Iñiguez Antonio Serra Luis Nombela-Franco Alfonso Ielasi Manel Sabaté 《Journal of the American College of Cardiology》2021,77(9):1165-1178
BackgroundOutcomes data for a durable-polymer everolimus-eluting stent (EES) at extended long-term follow-up in patients with ST-segment elevation myocardial infarction (STEMI) are unknown.ObjectivesThe aim of this study was to assess the 10-year outcomes of patients enrolled in the EXAMINATION (A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction) trial.MethodsThe EXAMINATION-EXTEND (10-Years Follow-Up of the EXAMINATION Trial) study is an investigator-driven 10-year follow-up of the EXAMINATION trial, which randomly assigned 1,498 patients with STEMI in a 1:1 ratio to receive either EES (n = 751) or bare-metal stents (n = 747). The primary endpoint was a patient-oriented composite endpoint of all-cause death, any myocardial infarction, or any revascularization. Secondary endpoints included a device-oriented composite endpoint of cardiac death, target vessel myocardial infarction, or target lesion revascularization; the individual components of the combined endpoints; and stent thrombosis.ResultsComplete 10-year clinical follow-up was obtained in 94.5% of the EES group and 95.9% of the bare-metal stent group. Rates of the patient-oriented composite endpoint and device-oriented composite endpoint were significantly reduced in the EES group (32.4% vs. 38.0% [hazard ratio: 0.81; 95% confidence interval: 0.68 to 0.96; p = 0.013] and 13.6% vs. 18.4% [hazard ratio: 0.72; 95% confidence interval: 0.55 to 0.93; p = 0.012], respectively), driven mainly by target lesion revascularization (5.7% vs. 8.8%; p = 0.018). The rate of definite stent thrombosis was similar in both groups (2.2% vs. 2.5%; p = 0.590). No differences were found between the groups in terms of target lesion revascularization (1.4% vs. 1.3%; p = 0.963) and definite or probable stent thrombosis (0.6% vs. 0.4%; p = 0.703) between 5 and 10 years.ConclusionsAt 10-year follow-up, EES demonstrated confirmed superiority in combined patient- and device-oriented composite endpoints compared with bare-metal stents in patients with STEMI requiring primary percutaneous coronary intervention. Between 5- and 10-year follow-up, a low incidence of adverse cardiovascular events related to device failure was found in both groups. (10-Years Follow-Up of the EXAMINATION Trial; NCT04462315) 相似文献
995.
Lorenzo Tarsitani Paolo Vassalini Alexia Koukopoulos Cristian Borrazzo Federica Alessi Chiara Di Nicolantonio Riccardo Serra Francesco Alessandri Giancarlo Ceccarelli Claudio Maria Mastroianni Gabriella dEttorre 《Journal of general internal medicine》2021,36(6):1702
BackgroundPost-traumatic stress disorder (PTSD) is a severe but treatable mental disorder that develops after a life-threatening traumatic event. Coronavirus disease 19 (COVID-19) hospitalisation is a potentially traumatic experience, especially in severe cases. Furthermore, the unprecedented context of the severe acute respiratory syndrome coronavirus 2 pandemic, with daily media bombardment about COVID-19 mortality, may have amplified life-threatening perception also in patients with moderate infection. The aim of this study was to assess the prevalence and risk factors of PTSD at 3-month follow-up in patients hospitalised for COVID-19 infection.DesignIn this cohort follow-up study conducted in a large Italian academic COVID-19 hospital, 115 recruited survivors were contacted by telephone 3 months after discharge to home care. The Posttraumatic Stress Disorder Checklist for DSM-5 was administered. Multivariate logistic regression models were used to analyse risk factors for the development of PTSD.Key ResultsA total of 10.4% of the sample received a PCL-5-based diagnosis of PTSD. Other 8.6% of the sample received a diagnosis of subthreshold PTSD, which leads to significant levels of distress and impairment. Multivariate regression analysis indicated that previous psychiatric diagnosis (odds ratio (OR) = 6.3, 95% confidence interval (CI): 3.7–78.6, p < 0.001) and obesity (OR = 3.51, 95% CI: 1.4–857.9, p = 0.03) were risk factors for developing PTSD. Chronic pulmonary diseases approached significance as a risk factor (OR = 6.03, 95% CI: 1.0–37.1, p = 0.053). Male sex was a protective factor (OR=0.04, 95% CI: 0.0–0.041, p = 0.007).ConclusionsPTSD and subthreshold PTSD rates in patients hospitalised for COVID-19 are worrying. Female sex and pre-existing mental disorders are established risk factors for PTSD, while the prospective association with obesity needs further investigation. Clinicians treating COVID-19 should consider screening for PTSD at follow-up assessments in patients discharged from the hospital.KEY WORDS: post-traumatic stress disorder, COVID-19, SARS-CoV-2, mental health, hospitalisation 相似文献
996.
The paper aims to determine whether the inflammation,a powerful risk factor that has been demonstrated for the development of coronary artery disease,plays a role in no-reflow phenomenon in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).Methods We prospectively analyzed 656 patients with AMI after primary PCI.Based on post-PCI angiography data,patients were divided into two groups:the no-reflow group (TIMI=2,n =60) and the reflow group (TIMI=3,n =596).Results Our results showed that the inflammatory factors including leukocyte count (×109/L) (10.90±4.04 vs.9.12±2.98 P =0.002),hs-CRP (5.04±0.71 vs.4.70±0.75 P =0.001) and other factor platelet count (×109/L) (210.96±33.42 vs.196.41±46.06 P =0.033) in no-reflow group are significantly higher than those in reflow group,major adverse cardiac events happened in the patients with no-reflow are higher than in reflow patients no matter in hospital or at the end of follow-up.We also found the left ventricular ejection fraction (LVEF) dramatically decreased (58.65±9.34 vs.51.29±11.38,P<0.001) and left ventricular end-diastolic dimension (LVEDD) significantly increased (49.94±6.75 mm vs.54.66±6.68mm,P<0.001) in no-reflow patients at the end of follow-up.Conclusions Our results suggest that inflammation factors function in no-reflow phenomenon,and no-reflow is a serious complication after primary PCI which predicts poor left ventricular systolic functional recovery and mortality in patients with AMI.(J Geriatr Cardiol 2008;5:217-222) 相似文献
997.
998.
999.
Laia Ribot Luna Emma García Grau Jordi Costa Pueyo Laura Serra Azuara M. Rosa Bella Cueto Yolanda Canet Estévez 《Progresos de Obstetricia y Ginecología》2009
Placental mesenchymal dysplasia (PMD) is a vascular abnormality with a very low incidence (0.02%) that is characterized by placentomegaly with multiple grapelike vesicles on ultrasound examination. The main differential diagnosis of PMD is partial hydatidiform mole. However, in contrast to a partial mole, PMD can coexist with a viable fetus. 相似文献
1000.